Sedana Medical AB SEDANA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 22.65
- Day Range
- SEK 21.30–22.75
- 52-Week Range
- SEK 13.88–34.50
- Bid/Ask
- SEK 21.60 / SEK 21.75
- Market Cap
- SEK 2.16 Bil
- Volume/Avg
- 257,344 / 275,030
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.64
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sedana Medical AB is a Sweden-based medical technology company. It is a pioneer MedTech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. The product range of the group is Sedaconda ACD, Sedaconda, AnaConDa, FlurAbsorb, Gas Monitor, Adapters, and Accessories. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 79
- Website
- https://www.sedanamedical.com
Comparables
Valuation
|
Metric
|
SEDANA
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 2.28 | 2.80 | 7.23 |
Price/Sales | 13.64 | — | 12.31 |
Price/Cash Flow | — | — | — |
Price/Earnings
SEDANA
ELOS B
BACTI B
Financial Strength
|
Metric
|
SEDANA
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Quick Ratio | 7.38 | 0.40 | 1.64 |
Current Ratio | 8.11 | 1.99 | 1.94 |
Interest Coverage | — | 6.73 | −11.31 |
Quick Ratio
SEDANA
ELOS B
BACTI B
Profitability
|
Metric
|
SEDANA
|
ELOS B
|
BACTI B
|
|---|---|---|---|
Return on Assets (Normalized) | −1.99% | 7.39% | −17.77% |
Return on Equity (Normalized) | −2.09% | 13.33% | −32.17% |
Return on Invested Capital (Normalized) | −5.40% | 12.76% | −19.44% |
Return on Assets
SEDANA
ELOS B
BACTI B
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nzynjdnpy | Ntpxfn | $184.4 Bil | |
SYK
| Stryker Corp | Tsxyjzvv | Ddzfg | $125.0 Bil | |
MDT
| Medtronic PLC | Fhqcqqzh | Nfbql | $107.4 Bil | |
BSX
| Boston Scientific Corp | Yjkkkfnqz | Nbcmgj | $106.2 Bil | |
EW
| Edwards Lifesciences Corp | Jbptmfkg | Wbxjjy | $50.8 Bil | |
DXCM
| DexCom Inc | Wxgxkwrqn | Wtxgj | $49.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Spjdzyqc | Vtgf | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Djpjmwdf | Zmcmsn | $24.4 Bil | |
ALGN
| Align Technology Inc | Njnlzzgjp | Mgktr | $21.4 Bil | |
PODD
| Insulet Corp | Vktpzsvbq | Ghvvqtp | $11.9 Bil |